No abstract available
Keywords:
Forodesine; Peripheral T-cell lymphoma (PTCL); Pralatrexate (PDX); Relapse/Refractory; Retreatment.
MeSH terms
-
Aged
-
Aminopterin / analogs & derivatives*
-
Aminopterin / therapeutic use
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cyclophosphamide / therapeutic use
-
Doxorubicin / therapeutic use
-
Female
-
Humans
-
Lymph Nodes / drug effects
-
Lymph Nodes / pathology
-
Lymphoma, T-Cell, Peripheral / drug therapy*
-
Lymphoma, T-Cell, Peripheral / pathology
-
Neoplasm Recurrence, Local / drug therapy*
-
Neoplasm Recurrence, Local / pathology
-
Prednisone / therapeutic use
-
Purine Nucleosides / therapeutic use*
-
Pyrimidinones / therapeutic use*
-
T-Lymphocytes, Helper-Inducer / drug effects
-
T-Lymphocytes, Helper-Inducer / pathology
-
Vincristine / therapeutic use
Substances
-
10-propargyl-10-deazaaminopterin
-
Antineoplastic Agents
-
Purine Nucleosides
-
Pyrimidinones
-
forodesine
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Aminopterin
-
Prednisone
Supplementary concepts
-
CHOP protocol
-
COP protocol 2